Condition: Esophageal Cancer
Interventions: Drug: SHR-1210; Radiation: IMRT or VMAT; Drug: Apatinib
Sponsors: Tianjin Medical University Cancer Institute and Hospital; Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting
https://ift.tt/2MvyUNv
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου